Vanguard Capital Management’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
Other funds holding IGC
LC
Vanguard Capital Management's IGC Position: Q3 2026 in Review
Vanguard Capital Management increased its IGC Pharma (IGC) stake by 6.8% in Q3 2026, buying an estimated $15.5K and bringing the position to 870,714 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3774.
Vanguard Capital Management first reported a position in IGC in Q1 2026 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold IGC as of Q3 2026.
- Vanguard Capital Management held 870,714 shares of IGC Pharma worth $234K as of Q3 2026.
- Vanguard Capital Management bought 55,800 IGC Pharma shares in Q3 2026, an estimated $15.5K.
- IGC Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3774 holding.
- Vanguard Capital Management first reported a position in IGC Pharma in Q1 2026 and has held it in 3 quarters since.
- 29 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.